These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26520056)

  • 1. Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children.
    Mancina RM; Sentinelli F; Incani M; Bertoccini L; Russo C; Romeo S; Baroni MG
    Dig Liver Dis; 2016 Jan; 48(1):100-1. PubMed ID: 26520056
    [No Abstract]   [Full Text] [Related]  

  • 2. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
    Coppola N; Rosa Z; Cirillo G; Stanzione M; Macera M; Boemio A; Grandone A; Pisaturo M; Marrone A; Adinolfi LE; Sagnelli E; Miraglia del Giudice E
    Liver Int; 2015 Aug; 35(8):1959-63. PubMed ID: 25581573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.
    Milano M; Aghemo A; Mancina RM; Fischer J; Dongiovanni P; De Nicola S; Fracanzani AL; D'Ambrosio R; Maggioni M; De Francesco R; Fargion S; Berg T; Stickel F; Hampe J; Romeo S; Colombo M; Valenti L
    Hepatology; 2015 Jul; 62(1):111-7. PubMed ID: 25820484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.
    Liu Z; Que S; Zhou L; Zheng S; Romeo S; Mardinoglu A; Valenti L
    Sci Rep; 2017 Aug; 7(1):9273. PubMed ID: 28839198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD.
    Luukkonen PK; Zhou Y; Nidhina Haridas PA; Dwivedi OP; Hyötyläinen T; Ali A; Juuti A; Leivonen M; Tukiainen T; Ahonen L; Scott E; Palmer JM; Arola J; Orho-Melander M; Vikman P; Anstee QM; Olkkonen VM; Orešič M; Groop L; Yki-Järvinen H
    J Hepatol; 2017 Jul; 67(1):128-136. PubMed ID: 28235613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
    Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
    Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.
    Dongiovanni P; Petta S; Maglio C; Fracanzani AL; Pipitone R; Mozzi E; Motta BM; Kaminska D; Rametta R; Grimaudo S; Pelusi S; Montalcini T; Alisi A; Maggioni M; Kärjä V; Borén J; Käkelä P; Di Marco V; Xing C; Nobili V; Dallapiccola B; Craxi A; Pihlajamäki J; Fargion S; Sjöström L; Carlsson LM; Romeo S; Valenti L
    Hepatology; 2015 Feb; 61(2):506-14. PubMed ID: 25251399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
    J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.
    Zhou Y; Llauradó G; Orešič M; Hyötyläinen T; Orho-Melander M; Yki-Järvinen H
    J Hepatol; 2015 Mar; 62(3):657-63. PubMed ID: 25457209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant.
    Mancina RM; Matikainen N; Maglio C; Söderlund S; Lundbom N; Hakkarainen A; Rametta R; Mozzi E; Fargion S; Valenti L; Romeo S; Taskinen MR; Borén J
    J Clin Endocrinol Metab; 2015 May; 100(5):E821-5. PubMed ID: 25763607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    Romeo S; Sentinelli F; Cambuli VM; Incani M; Congiu T; Matta V; Pilia S; Huang-Doran I; Cossu E; Loche S; Baroni MG
    J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of transmembrane 6 superfamily member 2 E167K gene knock-in mouse model by using CRISPR/Cas9 technology].
    Sun BK; Liu SS; Zhang J; Xuan SY; Xin YN
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):591-596. PubMed ID: 32791795
    [No Abstract]   [Full Text] [Related]  

  • 13. Disruption of the ERLIN-TM6SF2-APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease.
    Li BT; Sun M; Li YF; Wang JQ; Zhou ZM; Song BL; Luo J
    PLoS Genet; 2020 Aug; 16(8):e1008955. PubMed ID: 32776921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
    D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
    Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.
    Chen LZ; Xia HH; Xin YN; Lin ZH; Xuan SY
    J Clin Transl Hepatol; 2015 Dec; 3(4):265-70. PubMed ID: 26807382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
    Viganò M; Valenti L; Lampertico P; Facchetti F; Motta BM; D'Ambrosio R; Romagnoli S; Dongiovanni P; Donati B; Fargion S; Colombo M
    Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbation of
    Pant A; Chen Y; Kuppa A; Du X; Halligan BD; Speliotes EK
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age might confound the impact of the transmembrane 6 superfamily member 2 E167K polymorphism on hepatic fibrosis in hepatitis C virus-infected patients.
    Liu Z; Chen T; Wang Y; Zhang M; Zhou L; Zheng S
    Hepatology; 2016 Mar; 63(3):1052. PubMed ID: 25983139
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors related to non-alcoholic fatty liver disease in obese children.
    Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B
    Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with hepatic steatosis in obese children and adolescents.
    Ruiz-Extremera Á; Carazo Á; Salmerón Á; León J; Casado J; Goicoechea A; Fernandez JM; Garofano M; Ocete E; Martín AB; Pavón E; Salmerón J
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):196-201. PubMed ID: 21788762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.